| Reactome: a database of reactions, pathways and biological processes D Croft, G O’kelly, G Wu, R Haw, M Gillespie, L Matthews, M Caudy, ... Nucleic acids research 39 (suppl_1), D691-D697, 2010 | 1880 | 2010 |
| AMD3100 is a CXCR7 ligand with allosteric agonist properties I Kalatskaya, YA Berchiche, S Gravel, BJ Limberg, JS Rosenbaum, ... Molecular pharmacology 75 (5), 1240-1247, 2009 | 403 | 2009 |
| Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer Y Kim, V Ignatchenko, CQ Yao, I Kalatskaya, JO Nyalwidhe, RS Lance, ... Molecular & Cellular Proteomics 11 (12), 1870-1884, 2012 | 101 | 2012 |
| Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells JA Sprowl, K Reed, SR Armstrong, C Lanner, B Guo, I Kalatskaya, L Stein, ... Breast Cancer Research 14, 1-18, 2012 | 78 | 2012 |
| Mutation of tyrosine in the conserved NPXXY sequence leads to constitutive phosphorylation and internalization, but not signaling, of the human B2 bradykinin receptor I Kalatskaya, S Schussler, A Blaukat, W Muller-Esterl, M Jochum, D Proud, ... Journal of Biological Chemistry 279 (30), 31268-31276, 2004 | 72 | 2004 |
| ISOWN: accurate somatic mutation identification in the absence of normal tissue controls I Kalatskaya, QM Trinh, M Spears, JD McPherson, JMS Bartlett, L Stein Genome medicine 9, 1-18, 2017 | 65 | 2017 |
| Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma A Ismail, S Bandla, M Reveiller, L Toia, Z Zhou, WE Gooding, I Kalatskaya, ... Clinical Cancer Research 17 (13), 4513-4522, 2011 | 61 | 2011 |
| Detection of circulating tumor DNA in plasma: a potential biomarker for esophageal adenocarcinoma M Egyud, M Tejani, A Pennathur, J Luketich, P Sridhar, E Yamada, ... The Annals of thoracic surgery 108 (2), 343-349, 2019 | 53 | 2019 |
| Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation M Yu, G Lin, N Arshadi, I Kalatskaya, B Xue, S Haider, F Nguyen, ... Molecular and cellular biology, 2012 | 49 | 2012 |
| Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer M Egyud, P Sridhar, A Devaiah, E Yamada, S Saunders, A Stċhlberg, ... Head & neck 41 (5), 1351-1358, 2019 | 39 | 2019 |
| Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer M Braunstein, L Liao, N Lyttle, N Lobo, KJ Taylor, PM Krzyzanowski, ... Breast Cancer Research 18, 1-16, 2016 | 37 | 2016 |
| Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma I Kalatskaya Annals of the New York Academy of Sciences 1381 (1), 74-91, 2016 | 36 | 2016 |
| The role of helix 8 and of the cytosolic C‐termini in the internalization and signal transduction of B1 and B2 bradykinin receptors A Faussner, A Bauer, I Kalatskaya, S Schüssler, C Seidl, D Proud, ... The FEBS journal 272 (1), 129-140, 2005 | 34 | 2005 |
| Downregulation of bradykinin B2 receptor in human fibroblasts during prolonged agonist exposure A Blaukat, P Micke, I Kalatskaya, A Faussner, W Müller-Esterl American Journal of Physiology-Heart and Circulatory Physiology 284 (6 …, 2003 | 34 | 2003 |
| Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells M Reveiller, S Ghatak, L Toia, I Kalatskaya, L Stein, M D'Souza, Z Zhou, ... Annals of surgery 255 (6), 1113-1120, 2012 | 26 | 2012 |
| Expression levels strongly affect ligand-induced sequestration of B2 bradykinin receptors in transfected cells A Faussner, A Bauer, I Kalatskaya, M Jochum, H Fritz American Journal of Physiology-Heart and Circulatory Physiology 284 (6 …, 2003 | 26 | 2003 |
| Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA LC Sutherland, P Thibault, M Durand, E Lapointe, JM Knee, A Beauvais, ... BMC molecular biology 18, 1-14, 2017 | 22 | 2017 |
| Interruption of the ionic lock in the bradykinin B2 receptor results in constitutive internalization and turns several antagonists into strong agonists J Leschner, G Wennerberg, J Feierler, M Bermudez, B Welte, I Kalatskaya, ... Journal of Pharmacology and Experimental Therapeutics 344 (1), 85-95, 2013 | 22 | 2013 |
| Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma Z Zhou, I Kalatskaya, D Russell, N Marcon, M Cirocco, PM Krzyzanowski, ... Clinical and experimental gastroenterology, 219-229, 2019 | 19 | 2019 |
| Pathprinting: An integrative approach to understand the functional basis of disease GM Altschuler, O Hofmann, I Kalatskaya, R Payne, SJ Ho Sui, U Saxena, ... Genome medicine 5, 1-13, 2013 | 15 | 2013 |
